Novel Diagnostic Test Development
Our team brings together unique skill sets to tackle some of the world’s most devastating and burdensome diseases in both human healthcare and agriculture.
Our development pipeline includes various diagnostic technologies and supporting devices. Our ability to quickly adapt and utilize novel technologies allows us to develop solutions for widely unmet diagnostic needs that offer a true competitive advantage.
COVID-19 Clinical Lab
FYR Diagnostics is an accredited CLIA (Clinical Laboratory Improvement Amendments) licensed laboratory specializing in high-complexity diagnostic testing for COVID-19. Our current testing methodology utilizes EUA approved RT-qPCR technology coupled with an advanced automation platform. Additionally, we are actively working towards FDA clearance for the use of a laboratory developed test (LDT) that leverages the speed and efficiency of isothermal amplification technologies. Implementation of the FYR Diagnostics LDT will allow us to drastically increase our testing capacity and throughput in the coming months.